Pay in 4 interest-free payments of $6.33 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
at Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 8-11 April 2024
Phase 3 clinical trial data showed average weight loss of 28.7% of body weight (approximately 71.2 pounds) at the 12 mg dose over 68 weeks
Regional People with overweight, all classes of obesity, and T2D spotlighting the frequent concurrence of the two conditions Obesity x T2D overlap Wegovy and Zepbound are not FDA-approved to treat type 2 diabetes, but in clinical trials, in addition to losing weight, patients saw improvements in blood glucose levels
Prices of GLP-1 medications vary depending on the pharmacy and location where you fill your prescription
That is why retatrutide is a good choice for people who want to lose weight and deal with high blood sugar or heart problems
US$ 24.25
US$ 26.81
US$ 27.75
US$ 29.80
US$ 22.32
US$ 28.64
US$ 22.75
US$ 22.68
US$ 29.80
US$ 27.67
US$ 20.65
US$ 27.20
